Phathom Pharmaceuticals, Inc. (PHAT) stock
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.50−0.38 (-6.46%)
Close on Nov 17, 2026Market cap $447.10MP/E –Yield –
Phathom Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Phathom Pharmaceuticals's price to sales ratio was 2.1× on Nov 11, 2026, against 7.5× a year earlier. Over the last 3 years it ranged from 1.9× to 266.7×, with a median of 7.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.1× | −5.9 |
| 2025 | Dec 31, 2025 | 8.0× | −13.1 |
| 2024 | Dec 31, 2024 | 21.1× | – |
See a number that looks wrong?